Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Anticancer Research|August 5, 2006
Establishment and characterization of amylase-producing lung adenocarcinoma cell line, IMEC-2Hiroshi Yokouchi, Koichi Yamazaki, Hajime Asahina, et al.Anticancer Research|November 11, 2006
Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancerMegumi Nakadate, Koichi Yamazaki, Jun Konishi, et al.International Journal of Radiation Oncology, Biology, Physics|September 21, 2007
Histopathologic consideration of fiducial gold markers inserted for real-time tumor-tracking radiotherapy against lung cancerMikado Imura, Koichi Yamazaki, Kanako C Kubota, et al.International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapyHiroki Shirato, Toshiyuki Harada, Tooru Harabayashi, et al.American Journal of Physiology. Endocrinology and Metabolism|May 28, 2015
New CETP inhibitor K-312 reduces PCSK9 expression: a potential effect on LDL cholesterol metabolismKatsutoshi Miyosawa, Yuichiro Watanabe, Kentaro Murakami, et al.BMC Cancer|March 22, 2007
Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancerHiroshi Yokouchi, Koichi Yamazaki, Ichiro Kinoshita, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapyAkira Inoue, Kunihiko Kobayashi, Kazuhiro Usui, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402Akira Inoue, Shunichi Sugawara, Koichi Yamazaki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2009
Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutationsSatoshi Morita, Isamu Okamoto, Kunihiko Kobayashi, et al.Anticancer Research|April 9, 2005
Analysis of the response and toxicity to gefitinib of non-small cell lung cancerJun Konishi, Koichi Yamazaki, Ichiro Kinoshita, et al.Pageof 7